E-Cadherin Protein Expression Predicts Prostate Cancer Salvage Radiotherapy Outcomes

Journal of Urology

Volumn 176, Issue 4, 2006, Pages 1409-1414

  Ray, Michael E ^a   Mehra, Rohit ^a   Sandler, Howard M ^a   Daignault, Stephanie ^a   Shah, Rajal B ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

cadherins; prostate; prostatic neoplasms; radiotherapy; salvage therapy

Indexed keywords

HORMONE; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROTEIN EXPRESSION; RADIATION INJURY; SEMINAL VESICLE; UNIVARIATE ANALYSIS;

CADHERINS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 33748098541     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.06.014     Document Type: Article

References (20)

1. Pazona J.F., Han M., Hawkins S.A., Roehl K.A., and Catalona W.J. Salvage radiation therapy for prostate specific antigen progression following radical prostatectomy. 10-year outcome estimates. J Urol 174 (2005) 1282
2. Tsien C., Griffith K.A., Sandler H.M., McLaughlin P., Sanda M.G., Montie J., et al. Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy. Urology 62 (2003) 93
3. Stephenson A.J., Shariat S.F., Zelefsky M.J., Kattan M.W., Butler E.B., Teh B.S., et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 291 (2004) 1325
4. Eulau S.M., Tate D.J., Stamey T.A., Bagshaw M.A., and Hancock S.L. Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer. Int J Radiat Oncol Biol Phys 41 (1998) 735
5. Pollack A., Hanlon A.L., Pisansky T.M., Sandler H.M., Kuban D.A., Catton C., et al. A multi-institutional analysis of adjuvant and salvage radiotherapy after radical prostatectomy. Int J Radiat Oncol Biol Phys 60 (2004) S186
6. Yap A.S. The morphogenetic role of cadherin cell adhesion molecules in human cancer. a thematic review. Cancer Invest 16 (1998) 252
7. Umbas R., Schalken J.A., Aalders T.W., Carter B.S., Karthaus H.F., Schaafsma H.E., et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 52 (1992) 5104
8. Rubin M.A., Dunn R., Strawderman M., and Pienta K.J. Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol 26 (2002) 312
9. De Marzo A.M., Knudsen B., Chan-Tack K., and Epstein J.I. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens. Urology 53 (1999) 707
10. Umbas R., Isaacs W.B., Bringuier P.P., Schaafsma H.E., Karthaus H.F., Oosterhof G.O., et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 54 (1994) 3929
11. Richmond P.J., Karayiannakis A.J., Nagafuchi A., Kaisary A.V., and Pignatelli M. Aberrant E-cadherin and alpha-catenin expression in prostate cancer. correlation with patient survival. Cancer Res 57 (1997) 3189
12. Brewster S.F., Oxley J.D., Trivella M., Abbott C.D., and Gillatt D.A. Preoperative p53, bcl-2, CD44 and E-cadherin immunohistochemistry as predictors of biochemical relapse after radical prostatectomy. J Urol 161 (1999) 1238
13. Wu T.T., Hsu Y.S., Wang J.S., Lee Y.H., and Huang J.K. The role of p53, bcl-2 and E-cadherin expression in predicting biochemical relapse for organ confined prostate cancer in Taiwan. J Urol 170 (2003) 78
14. Moul J.W. Prostate specific antigen only progression of prostate cancer. J Urol 163 (2000) 1632
15. Quinn D.I., Henshall S.M., and Sutherland R.L. Molecular markers of prostate cancer outcome. Eur J Cancer 41 (2005) 858
16. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251 (1991) 1451
17. Gumbiner B.M. Cell adhesion. the molecular basis of tissue architecture and morphogenesis. Cell 84 (1996) 345
18. Wheelock M.J., and Johnson K.R. Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 19 (2003) 207
19. Rubin M.A., Mucci N.R., Figurski J., Fecko A., Pienta K.J., and Day M.L. E-cadherin expression in prostate cancer. a broad survey using high-density tissue microarray technology. Hum Pathol 32 (2001) 690
20. Ross J.S., Figge H.L., Bui H.X., del Rosario A.D., Fisher H.A., Nazeer T., et al. E-cadherin expression in prostatic carcinoma biopsies. correlation with tumor grade, DNA content, pathologic stage, and clinical outcome. Mod Pathol 7 (1994) 835